Key result
Dexamethasone inhibited the angiotensin II-induced increase in glomerular endothelial cell monolayer permeability and F-actin depolymerisation.
Why the study?
Does dexamethasone prevent angiotensin II-induced changes in monolayer permeability and F-actin distribution in glomerular endothelial cells?
Does dexamethasone prevent angiotensin II-induced changes in monolayer permeability and F-actin distribution in glomerular endothelial cells?
Dexamethasone protects glomerular endothelial cells from angiotensin II-induced injury by preventing increased permeability and F-actin depolymerisation in vitro.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for dexamethasone in angiotensin II-mediated glomerular endothelial injury; human studies required before clinical consideration.
The aim of this study was to investigate the changes in monolayer permeability and F-actin distribution caused by angiotensin II (Ang II)-induced injury in glomerular endothelial cells (GENCs) and the effects of dexamethasone on these changes. GENCs isolated and cultured from Wistar rats were used to examine the changes in monolayer permeability and F-actin distribution induced by Ang II. GENC permeability was evaluated by measuring the diffusion of biotin-conjugated bovine serum albumin (biotin-BSA) across a cell monolayer. The expression levels and distribution of F-actin were assessed by flow cytometry. The biotin-BSA concentrations were measured by capture enzyme-linked immunosorbent assay. Ang II at a concentration of 10 mg/l increased the permeability of the GENC monolayer at 6 h and 12 h (P<0.05 and P<0.01, respectively) and caused F-actin depolymerisation at 6 h and 12 h (P<0.01). The two effects attributed to Ang II were significantly inhibited by dexamethasone treatment (P<0.01). The increased permeability of the GENC monolayer induced by Ang II was significantly correlated with the depolymerisation of F-actin. Dexamethasone abrogated the Ang II-mediated damage to GENCs indicating that it may play an important role in protecting GENCs from injury.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2013) studied Angiotensin II-induced injury in glomerular endothelial cells (n=25). Dexamethasone vs. Angiotensin II alone (10 mg/l) was evaluated on Glomerular endothelial cell monolayer permeability (albumin clearance %) (p=<0.01). Dexamethasone inhibited the angiotensin II-induced increase in glomerular endothelial cell monolayer permeability and F-actin depolymerisation.
Synapse has enriched 10 related papers. Consider them for comparative context: